FDA flags risk of dental issues from use of opioid addiction drug buprenorphine

By

By Reuters Staff

(Reuters) - The U.S. health regulator on Wednesday warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat opioid addiction and pain.

The Food and Drug Administration said the opioid addiction treatment has been reported to cause tooth decay, infection, and, in some cases, total tooth loss in patients with no history of dental issues. (https://bit.ly/3fiJEj8)

The buprenorphine medicines that are associated with dental problems are tablets dissolved under the tongue and films placed against the inside of the cheek.

The FDA, which approved buprenorphine as a tablet in 2002 and as a film in 2015, said patients may lessen their risk by taking preventative measures, including waiting for at least one hour before brushing their teeth after use of the product.

The regulator's approved buprenorphine products include Orexo's Zubsolv, Indivior's Suboclade, among others.

The benefits of buprenorphine medicines for opioid use disorder and pain clearly outweigh the risks, and are important tools in treating these conditions, the FDA said.

Related Articles

Healthy lifestyle interventions may be best started in preschool

By Linda Carroll (Reuters Health) - Implementing school-based programs aimed at teaching healthy cardiovascular habits starting in preschool can achieve lasting lifestyle changes in children, Read More »

Canada approves Pfizer's oral COVID-19 antiviral treatment, seeks supplies

By David Ljunggren and Ismail Shakil OTTAWA (Reuters) - Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in people aged 18 and older but said Read More »

Secondhand vaping linked with respiratory symptoms in young adults

By Linda Carroll (Reuters Health) - Exposure to secondhand vape at home may be linked to a heightened risk for respiratory symptoms in young adults, a new study suggests. An analysis of data from Read More »